Skip to main content
. 2022 Feb 13;23:137. doi: 10.1186/s13063-022-06036-y

Fig. 2.

Fig. 2

Treatment scheme. C1, Cohort 1; C2, Cohort 2; CT th/abd, CT-scan of the chest and abdomen; MRI, magnetic resonance imaging; Chemosaturation, percutaneous hepatic perfusion; Inline graphic, PBMC; Inline graphic, CT Th/abd, MRI liver; Inline graphic, tumor biopsy